Such results are about double what older weight-loss drugs achieve, according to a 2021 article published in the New England Journal of Medicine
doi: 10.1111/jcmm.15489 107
Shima Hadidchi, MD , will work closely with you to set realistic expectations, discuss potential benefits and side effects, and develop a comprehensive plan tailored to your individual needs
Lipid raft microdomains and neurotransmitter signalling
Intestinal obstruction Recent reports have led to the FDA updating labeling for some GLP-1 agonists, including Ozempic, to include a warning about intestinal blockage (ileus)
Expertise in Carbon Markets and ACCUs The LGI team applies proven capability to optimise biogas extraction for carbon abatement and creation of Australian Carbon Credit Units (ACCUs), as well as to generate renewable energy and large scale renewable credits (LGCs)